Does APIXABAN Cause Malignant neoplasm progression? 251 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 251 reports of Malignant neoplasm progression have been filed in association with APIXABAN (ELIQUIS). This represents 0.2% of all adverse event reports for APIXABAN.
251
Reports of Malignant neoplasm progression with APIXABAN
0.2%
of all APIXABAN reports
81
Deaths
154
Hospitalizations
How Dangerous Is Malignant neoplasm progression From APIXABAN?
Of the 251 reports, 81 (32.3%) resulted in death, 154 (61.4%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 251 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which APIXABAN Alternatives Have Lower Malignant neoplasm progression Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ